Phase 3, randomized, placebo-controlled trials evaluating glasdegib in combination with intensive or nonintensive chemotherapy in patients with untreated acute myeloid leukemia
Jorge E. Cortes, Hervé Dombret, Akil Abid Merchant, Tetsuzo Tauchi, Christine DiRienzo, Mirjana Zeremski, Barbara Sleight, Xiaoxi Zhang, Mohammed Naveed Shaik, Timothy Bell, …
Journal of clinical oncology, Vol.36(15_suppl), pp.TPS7073-TPS7073
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.108 Molecular & Cell Biology - Cancer & Development
1.108.1856 Hedgehog
Web Of Science research areas
Oncology
ESI research areas
Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Details
Title
Phase 3, randomized, placebo-controlled trials evaluating glasdegib in combination with intensive or nonintensive chemotherapy in patients with untreated acute myeloid leukemia
Creators
Jorge E. Cortes - The University of Texas MD Anderson Cancer Center
Hervé Dombret - Hôpital Saint-Louis
Akil Abid Merchant - University of Southern California
Tetsuzo Tauchi - Tokyo Medical University
Christine DiRienzo - Pfizer
Mirjana Zeremski - Pfizer
Barbara Sleight - Pfizer
Xiaoxi Zhang - Pfizer
Mohammed Naveed Shaik - Pfizer
Timothy Bell - Pfizer
Geoffrey Chan - Pfizer
Mikkael A. Sekeres - Cleveland Clinic
Publication Details
Journal of clinical oncology, Vol.36(15_suppl), pp.TPS7073-TPS7073
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology